GRAND BAOXIN (01293) further delays the publication of its full-year performance for 2024.
Guanghui Baoxin (01293) issues announcement that as of the date of this announcement, the group's financial year ending on December 31, 2024...
GRAND BAOXIN (01293) Announcement: As of the date of this announcement, the audit of the Group's comprehensive annual performance for the year ended December 31, 2024 is still not completed. This is due to the Company's auditor further adjusting the audit procedures to fulfill and complete the necessary audit procedures for the full-year performance of 2024 and to ensure that industry and company changes are reasonably reflected in the Group's comprehensive financial statements for the year ended December 31, 2024.
The Company hereby emphasizes that the Group's operations remain normal and will continue to make maximum efforts to assist the auditor in completing the required audit procedures in order to resolve outstanding issues and complete the audit of the full-year performance of 2024 as soon as practicable. Therefore, in order to ensure the accuracy and completeness of the announcement of the full-year performance of 2024, and based on cautious considerations, the announcement of the full-year performance of 2024 will be further delayed. The current estimated publication date will be on or before August 29, 2025, but will only be finalized after completion of all audit work agreed upon with the auditor.
Related Articles

US Stock Market Move | Upstart (UPST.US) surged over 8.7%, Bank of America Securities maintained its "hold" rating.

US Stock Market Move | Mipletamig therapy achieves an 85% remission rate in leukemia patients. Aptevo Therapeutics (APVO.US) surges over 130%.

US Stock Market Move | Crude oil sector declines, Houston American Energy Corp. (HUSA.US) falls over 16%.
US Stock Market Move | Upstart (UPST.US) surged over 8.7%, Bank of America Securities maintained its "hold" rating.

US Stock Market Move | Mipletamig therapy achieves an 85% remission rate in leukemia patients. Aptevo Therapeutics (APVO.US) surges over 130%.

US Stock Market Move | Crude oil sector declines, Houston American Energy Corp. (HUSA.US) falls over 16%.
